Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity

Biochemical and Biophysical Research Communications

Volumn 421, Issue 1, 2012, Pages 33-37

  Ha, Bin ^a   Kim, Eun Kyung ^a   Kim, Ji Hee ^a   Lee, Hae Na ^a   Lee, Kyun Oh ^b   Lee, Sang Yeol ^b   Jang, Ho Hee ^a  

^a Gachon University College of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

E cadherin; Epithelial mesenchymal transition; HPrx1; Peroxidase activity; TGF 1

Indexed keywords

PEROXIDASE; PEROXIREDOXIN 1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL STRAIN A549; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOCARCINOMA; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; PEROXIDASE; PEROXIREDOXINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

GASTROPODA;

EID: 84860325478     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.103     Document Type: Article

References (29)

1. Shintani Y., Okimura A., Sato K., Nakagiri T., Kadota Y., Inoue M., Sawabata N., Minami M., Ikeda N., Kawahara K., Matsumoto T., Matsuura N., Ohta M., Okumura M. Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann. Thorac. Surg. 2011, 92:1794-1804.
2. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
3. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
4. Zhang K.H., Tian H.Y., Gao X., Lei W.W., Hu Y., Wang D.M., Pan X.C., Yu M.L., Xu G.J., Zhao F.K., Song J.G. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res. 2009, 69:5340-5348.
5. Moustakas A., Heldin C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007, 98:1512-1520.
6. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
7. Yang Y., Pan X., Lei W., Wang J., Song J. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 2006, 25:7235-7244.
8. Derynck R., Akhurst R.J. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat. Cell Biol. 2007, 9:1000-1004.
9. Kang S.W., Chae H.Z., Seo M.S., Kim K., Baines I.C., Rhee S.G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J. Biol. Chem. 1998, 273:6297-6302.
10. Wong C.M., Chun A.C., Kok K.H., Zhou Y., Fung P.C., Kung H.F., Jeang K.T., Jin D.Y. Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid. Redox Signal. 2000, 2:507-518.
11. Jang H.H., Lee K.O., Chi Y.H., Jung B.G., Park S.K., Park J.H., Lee J.R., Lee S.S., Moon J.C., Yun J.W., Choi Y.O., Kim W.Y., Kang J.S., Cheong G.W., Yun D.J., Rhee S.G., Cho M.J., Lee S.Y. Two enzymes in one: two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004, 117:625-635.
12. 2-induced cell death. J. Biol. Chem. 2005, 280:28775-28784.
13. Hirotsu S., Abe Y., Okada K., Nagahara N., Hori H., Nishino T., Hakoshima T. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23kDa/proliferation-associated gene product. Proc. Natl. Acad. Sci. USA 1999, 96:12333-12338.
14. Shau H., Gupta R.K., Golub S.H. Identification of a natural killer enhancing factor (NKEF) from human erythroid cells. Cell. Immunol. 1993, 147:1-11.
15. Mu Z.M., Yin X.Y., Prochownik E.V. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J. Biol. Chem. 2002, 277:43175-43184.
16. Wen S.T., Van Etten R.A. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 1997, 11:2456-2467.
17. Yanagawa T., Iwasa S., Ishii T., Tabuchi K., Yusa H., Onizawa K., Omura K., Harada H., Suzuki H., Yoshida H. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett. 2000, 156:27-35.
18. Yanagawa T., Ishikawa T., Ishii T., Tabuchi K., Iwasa S., Bannai S., Omura K., Suzuki H., Yoshida H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 1999, 145:127-132.
19. Noh D.Y., Ahn S.J., Lee R.A., Kim S.W., Park I.A., Chae H.Z. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001, 21:2085-2090.
20. Chang J.W., Lee S.H., Jeong J.Y., Chae H.Z., Kim Y.C., Park Z.Y., Yoo Y.J. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett. 2005, 579:2873-2877.
21. Chang J.W., Jeon H.B., Lee J.H., Yoo J.S., Chun J.S., Kim J.H., Yoo Y.J. Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun. 2001, 289:507-512.
22. Chen M.F., Keng P.C., Shau H., Wu C.T., Hu Y.C., Liao S.K., Chen W.C. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:581-591.
23. Thomson S., Buck E., Petti F., Griffin G., Brown E., Ramnarine N., Iwata K.K., Gibson N., Haley J.D. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005, 65:9455-9462.
24. Tsuji T., Ibaragi S., Hu G.F. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009, 69:7135-7139.
25. Cao J., Schulte J., Knight A., Leslie N.R., Zagozdzon A., Bronson R., Manevich Y., Beeson C., Neumann C.A. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 2009, 28:1505-1517.
26. Medici D., Hay E.D., Olsen B.R. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell 2008, 19:4875-4887.
27. Willis B.C., duBois R.M., Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc. 2006, 3:377-382.
28. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
29. Gotzmann J., Huber H., Thallinger C., Wolschek M., Jansen B., Schulte-Hermann R., Beug H., Mikulits W. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J. Cell Sci. 2002, 115:1189-1202.